Duke Sports Medicine, Durham, North Carolina, USA.
Am J Sports Med. 2011 Jul;39(7):1522-7. doi: 10.1177/0363546510397815. Epub 2011 Mar 3.
Achilles tendon rupture is a frequent injury in athletes and the general public. Cases of chronic rupture or poor tendon quality secondary to tendinopathy are challenging to repair primarily. Commercially available extracellular matrix materials have been utilized in recent years to augment tendon repair.
Augmentation of Achilles tendon with extracellular matrix xenograft results in reduced repair site gapping and increased peak failure load in a cadaveric model featuring simulated physiologic loads.
Controlled laboratory study.
Ten matched pairs of fresh-frozen human lower extremities amputated just below the knee were obtained and each Achilles tendon was sharply tenotomized. One randomly selected specimen from each matched pair underwent Achilles repair using a 4-strand Krackow technique with extracellular matrix xenograft augmentation (TissueMend Soft Tissue Repair Matrix), while the opposite tendon underwent suture repair alone as a control. Each tendon was then subjected to 1000 sinusoidal tensile loading cycles to 86 N during which repair site gapping was monitored, followed by distraction to failure. One pair was used to evaluate the effects of graft orientation and not included in the analysis.
Significantly less gapping was noted in the augmented tendon group at all time points after the 10th load cycle (P < .05). The mean repair site gapping after 1000 cycles of loading was 4.0 mm (range, 3.1-5.0 mm) in the augmented group and 6.5 mm (range, 4.1-8.6 mm) in the suture-only group. The ultimate failure load was 821 N (range, 613-1021 N) in the augmented group and 392 N (range, 322-481 N) in the suture-only group (P < .01).
The augmentation of Achilles tendon repair with extracellular matrix xenograft decreases gapping and increases load to failure immediately after surgery in a cadaveric model.
Tendon repair augmentation may allow more aggressive early rehabilitation, particularly in cases of chronic rupture or poor tendon quality. Further work is necessary to define indications for extracellular matrix graft augmentation of tendon repairs.
跟腱断裂是运动员和普通人群中常见的损伤。继发于腱病的慢性跟腱断裂或跟腱质量差的情况,初次修复具有挑战性。近年来,已有商业化的细胞外基质材料被用于增强跟腱修复。
在模拟生理负荷的尸体模型中,使用细胞外基质异种移植物增强跟腱可减少修复部位的间隙,并增加峰值失效负荷。
对照实验室研究。
从 10 对新鲜冷冻的膝关节以下截肢的人体下肢中各获得一个标本,并对每个跟腱进行锐性切断。从每对匹配的标本中随机选择一个标本,采用 4 股 Krackow 技术,并用细胞外基质异种移植物(TissueMend 软组织修复基质)进行增强修复,而对侧跟腱则单独缝合修复作为对照。然后,每个肌腱都要经过 1000 个正弦拉伸循环,在 86 N 的张力下,监测修复部位的间隙,然后再进行拉伸至失效。一对标本用于评估移植物方向的影响,未包括在分析中。
在第 10 次加载循环后的所有时间点,增强组的跟腱间隙明显较小(P<.05)。在经过 1000 次加载循环后,增强组的修复部位间隙平均值为 4.0mm(范围,3.1-5.0mm),而单纯缝合组为 6.5mm(范围,4.1-8.6mm)。增强组的最终失效负荷为 821N(范围,613-1021N),单纯缝合组为 392N(范围,322-481N)(P<.01)。
在尸体模型中,用细胞外基质异种移植物增强跟腱修复可减少术后即刻的间隙,并增加失效负荷。
肌腱修复增强可能允许更积极的早期康复,特别是在慢性断裂或肌腱质量差的情况下。进一步的工作需要确定细胞外基质移植物增强肌腱修复的适应证。